ARSB and digestive system cancer: Investigation of the role of the enzyme ARSB in other malignancies has shown that decline in ARSB is associated with more aggressive prostate and colon malignancies and that ARSB activity is reduced in malignant mammary cells and tissue compared to normal [18–22].